Citseko Staples Miller | Managing Director, Public Affairs
FTI Consulting, Inc.

Citseko Staples Miller, Managing Director, Public Affairs, FTI Consulting, Inc.

Citseko Staples Miller leads FTI Consulting’s Healthcare & Life Sciences Public Affairs team in Washington, DC. Ms. Miller is an experienced public affairs and policy expert who has been engaged in comprehensive, multi-faceted public affairs campaigns at the national, federal, state, and local levels for more than two decades. She helps organizations design and execute research-informed, comprehensive strategic communications and issues engagement campaigns to reach key stakeholder audiences. Ms. Miller has supported clients, including patient and consumer advocacy organizations, hospitals/health systems, cancer centers, payers, providers, life science companies, and a variety of other healthcare organizations. She has in-depth knowledge and experience on policy related to Medicaid, cancer prevention and early detection, HPV and immunization, and health equity. Prior to joining FTI, she served in staff leadership roles at the American Cancer Society Cancer Action Network (ACS CAN), WellCare Health Plans, and the executive and legislative branches in the State of Illinois.   Citseko Staples Miller leads FTI Consulting’s Healthcare & Life Sciences Public Affairs team. For over 20 years, Ms. Miller has been engaged in multi-faceted public policy campaigns focused on healthcare, access to coverage, cancer prevention, vaccines, appropriations and government finance. She helps organizations design and execute comprehensive strategic communications and issues engagement campaigns to reach diverse audiences. Ms. Miller’s client work, includes patient and consumer advocacy organizations, hospitals/health systems, cancer centers, payers, providers and life science companies. Prior to joining FTI, she served in staff leadership roles at the American Cancer Society Cancer Action Network (ACS CAN), WellCare Health Plans, and the executive and legislative branches in the State of Illinois.

Appearances:



Pre-Congress Workshops - 21st April @ 14:00

HPV ELIMINATION

Achieving Cervical Cancer Elimination through Prevention: Headwinds and Tailwinds

HPV-related cancers are preventable, yet the most effective evidence-based intervention to prevent and eliminate the disease, vaccination faces escalating opposition and misinformation, and an erosion of public trust, jeopardizing the critical progress toward achieving Cervical Cancer Elimination by 2030. At the same time, recent approvals of new self-sampling technology has the promise to help diagnose illness sooner and prompt early intervention. This session will bring together public health, cancer prevention, immunization, screening, and patient advocacy experts and leaders in the U.S. to discuss strategies for safeguarding HPV-cancer prevention efforts, while exploring policy solutions, breakthrough research, and cross-sector collaboration. Panelists will address the urgent need to protect current progress and accelerate and intensify efforts toward eliminating HPV-related cancers, starting with Cervical Cancer. The session will culminate in an interactive strategy session where participants will develop a Top 10 Essential Actions framework—a consensus-driven roadmap to achieve the goals of Cervical Cancer Elimination. 

Session led by: merck
last published: 22/Apr/25 15:25 GMT

back to speakers